Medicare Freeze: A Desperate Move Against Healthcare Crooks, Or Just More Red Tape?

POLICY WIRE — Washington D.C. — They’re not exactly closing the barn door after the horse has bolted. More like, the horse bolted, brought its whole criminal family, — and started renting out stalls for ill-gotten gains. Now, Uncle Sam’s brought out the cement mixer, trying to seal off new entry points into the sprawling, multi-trillion-dollar Medicare stable. The Centers for Medicare & Medicaid Services (CMS) has slammed the brakes, halting new provider enrollments for home health agencies and hospice care across swathes of the country, and that’s got some folks cheering, others fuming.

It’s an aggressive, if blunt, tactic, targeting areas notorious for healthcare fraud. Think places like Miami-Dade, parts of Texas, Michigan—you get the drift. No new providers in these zones, not for now, at least. It’s less about stopping the existing bad actors (that’s another story entirely, and a much harder one to tell) and more about cutting off the supply chain for new ones. But when you hit the ‘off’ switch, it’s not always just the crooks who get burned, is it? Legitimate startups, those actually trying to do good work, they’re caught in the regulatory crossfire, too. And patients? Well, we’ll get to them.

Because frankly, the problem’s massive. And it costs us all. According to CMS’s own numbers, something like $60 billion annually is lost to Medicare and Medicaid fraud, waste, and abuse. That’s a staggering figure—enough to make even the most hardened budget hawk blink. The new moratorium isn’t just an administrative tweak; it’s a declaration. They’re fed up. This isn’t the first time they’ve done it, either, nor will it be the last. Each time, the cry goes up: will it actually work, or just reroute the scam artists?

Secretary Xavier Becerra, never one to mince words when taxpayer dollars are on the line, has been quite clear about the government’s stance. “Look, we’re stewards of taxpayer dollars,” he might say, a practiced weariness in his voice, given his years in various public offices. “We’ve got to stop the bleed. It’s not a choice; it’s a responsibility. Tough measures, yes, but necessary if we’re going to protect this program for the seniors who actually need it.” He’s playing to the gallery, sure, but he’s also speaking a fundamental truth: unchecked fraud corrodes public trust and drains vital resources. You can’t argue with that.

But the industry sees it differently. “This hits good operators, too,” warns Joanne Jenkins, President of the National Association for Home Care & Hospice. “Patients in underserved areas? They’re the ones who really lose out. We need smarter oversight, not blanket bans. What about the entrepreneurial spirit, the genuine folks trying to start services where they’re desperately needed? This just makes it harder for everyone.” And she’s got a point. When the door slams shut, it doesn’t always distinguish between saint — and sinner.

This is especially complex in communities where care needs are rapidly expanding, and where cultural nuances often play a significant role in who seeks and provides home health. Take the burgeoning Pakistani-American community in Houston, for instance, or other diasporic groups across major metropolitan areas. They’ve built networks of care providers, often rooted in shared language — and cultural understanding. Many have come to the U.S. as healthcare professionals, drawn by the opportunities—it’s an inspiring narrative of migration and contribution. Now, if someone from this community wants to open a new agency to serve their elderly parents and neighbors, genuinely meeting a critical need, they’re effectively locked out in a stroke. It isn’t just frustrating; it’s a barrier to community-led solutions.

And let’s be honest, for many, home healthcare is the humane, and often economically sensible, alternative to institutional living. To kneecap its expansion, even with the best intentions, is to tell countless families that their elderly or ailing loved ones might just have fewer options. It’s a bureaucratic tightening, sure. But its impact on real lives is undeniable. The government, in its ceaseless quest to streamline what’s, admittedly, a bit of a chaotic economic monster (the U.S. healthcare system), often forgets the little guys caught underfoot.

What This Means

This moratorium isn’t just about closing loopholes; it’s about shifting the market dynamics. Economically, it chokes off competition in affected areas, potentially entrenching existing, perhaps even underperforming, providers. Fewer choices generally mean less incentive for quality improvement and possibly higher costs over time as demand outstrips stagnant supply. Politically, it’s a win for CMS to show it’s ‘doing something’ about fraud, an easily digestible soundbite for an electorate fatigued by wasteful spending. But the long-term implications are messy.

It’s a zero-sum game that pits anti-fraud vigilance against patient access — and innovation. Expect existing providers to see a temporary bump in value, shielded from new entrants. But don’t expect the fraud itself to vanish. Historically, these efforts push criminal enterprises to evolve, finding new angles, new places, or simply new types of fraud to exploit. We’ve seen this pattern with everything from opioid crackdowns to identity theft—the beast just shifts its shape. This particular maneuver could also trigger unintended consequences: a rise in informal, unregulated care, or even black markets for care where vulnerable people are even more exposed. And it could make it even tougher for legitimate small businesses, many owned by immigrants and minority groups, to grow. You want more proof of the U.S. health system’s brutal economy? Just read the regulatory tea leaves. It doesn’t exactly signal a smooth path forward for everyone.